Form 8-K - Current report:
SEC Accession No. 0001558370-22-000487
Filing Date
2022-01-27
Accepted
2022-01-27 10:01:43
Documents
12
Period of Report
2022-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20220127x8k.htm   iXBRL 8-K 35251
  Complete submission text file 0001558370-22-000487.txt   157656

Data Files

Seq Description Document Type Size
2 EX-101.SCH tgtx-20220127.xsd EX-101.SCH 3357
3 EX-101.LAB tgtx-20220127_lab.xml EX-101.LAB 16029
4 EX-101.PRE tgtx-20220127_pre.xml EX-101.PRE 11027
6 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20220127x8k_htm.xml XML 4871
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 22560546
SIC: 2834 Pharmaceutical Preparations